Search - tctmd.com

Displaying 301 - 320 of 471

Sort: Relevancy | Date

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

News Daily News

Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood

Yael L. Maxwell

April 11, 2018

News Daily News

Respiratory Syncytial Virus Linked With Cardiovascular Complications

Michael O'Riordan

April 04, 2018

News Daily News

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Yael L. Maxwell

March 30, 2018

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

News Conference News ACC 2018

Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later

Caitlin E. Cox

February 28, 2018

News Daily News

‘High Index of Suspicion’ First Step in Successful Management of SCAD

Michael O'Riordan

February 27, 2018

News Daily News

Genetic Tendency Toward Depression Signals a Higher Ischemic Stroke Risk

Todd Neale

February 14, 2018

News Daily News

Beyond LDL Cholesterol: Lipoprotein Particles Linked With MI and Ischemic Stroke

Michael O'Riordan

February 07, 2018

News Daily News

Just One Cigarette Daily Raises Coronary Disease and Stroke Risks: Meta-analysis

Caitlin E. Cox

January 26, 2018

News Daily News

Heart Rate Changes Over Time Hint at Higher Cardiovascular Risk

Michael O'Riordan

January 25, 2018

News Daily News

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Caitlin E. Cox

January 18, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Caitlin E. Cox

January 08, 2018

News Daily News

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Michael O'Riordan

December 12, 2017

News Daily News

Genetic Study Hints at Role of Lipids in AAA Risk

Michael O'Riordan

November 30, 2017

Presentation Controversies and Advances 2017

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Presenter: Sanjay Kaul

November 16, 2017

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

Todd Neale

November 14, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

Advertisement

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

Childhood Obesity Can Affect Cardiovascular Risk Even If Resolved by Adulthood

Respiratory Syncytial Virus Linked With Cardiovascular Complications

High-Sensitivity Troponins May Help Identify Obstructive CAD in Stable, Symptomatic Patients

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Preeclampsia During Pregnancy Linked With CV Consequences Many Years Later

‘High Index of Suspicion’ First Step in Successful Management of SCAD

Genetic Tendency Toward Depression Signals a Higher Ischemic Stroke Risk

Beyond LDL Cholesterol: Lipoprotein Particles Linked With MI and Ischemic Stroke

Just One Cigarette Daily Raises Coronary Disease and Stroke Risks: Meta-analysis

Heart Rate Changes Over Time Hint at Higher Cardiovascular Risk

Symptomatic Myocardial Ischemia but No Obstructive CAD: Some Drugs Work, Others Don’t, Review Finds

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Genetic Study Hints at Role of Lipids in AAA Risk

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content